Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Opioids
FDA Remains Focused on Opioid Crisis, New Guidance Developing
Recently, the United States Food & Drug Administration (FDA) Commissioner Scott Gottlieb released a statement highlighting the…
New Book on Opioid Crisis and Possible Solutions
We all know that the opioid crisis we are currently facing is unlike anything we have seen before. Dave Chase, co-founder of…
Senate Expected to Vote on Opioid Legislation includes Expansion of Open…
Last Thursday, Senate leaders announced that they had reached an agreement to bring a package of bills to address the nation's…
Gottlieb Highlights New Steps to Guide Opioid Prescribing
On August 22, 2018, United States Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., released a statement on…
Insys Agrees to Settlement Regarding Opioid Sales Probe
On Wednesday, August 8, 2018, Insys Therapeutics announced a deal to pay $150 million to resolve the United States Department of…
FDA Releases Draft Guidance on New MAT Opioid Use Disorder Treatments
On August 6, 2018, the United States Food and Drug Administration (FDA) released draft guidance, Opioid Use Disorder: Endpoints…
Doctors Do Their Part in the Battle Against Opioids
In a report released by the American Medical Association (AMA) , it was found that nationwide, more than 19 million fewer…
Swarming on the Opioid Crisis (Part 2)
This is the second article in the series exploring the major themes emerging from recent efforts to combat the ‘opioid crisis’ and…
Are Doctors Really Influenced by the Pharmaceutical Industry?
Recently, Rafael Fonseca, MD and John A. Tucker, MBA, PhD, issued a critical analysis of a recent study that drew correlations…
MEDX Rockpointe Primary Care 2018 Conferences feature 3 hours of education…
In an effort to fight the opioid crisis and to help physicians and other health care providers meet state CME requirements for…